NDC codes

FDA NDC Directory
Product NDC (as listed)0002-6612Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00002-6612Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0002-6612-11000026612111 VIAL, MULTI-DOSE in 1 CARTON (0002-6612-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-6612-01)Marketed from Jan 7, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Zepbound
Generic name (nonproprietary)
tirzepatide
Active ingredients
Tirzepatide25 mg/mL
Dosage form
Injection, Solution
Route
Subcutaneous
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 217806
Marketing start
Listing expires
Other FDA classes
G-Protein-linked Receptor Interactions (Mechanism)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)
Identifiers
Product ID 0002-6612_a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fcSPL ID a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fcSPL set ID 487cd7e7-434c-4925-99fa-aa80b1cc776bRxCUI 2601743, 2601755, 2601761, 2601767, 2601773, 2601784, 2644396, 2644401, 2644405, 2644409, 2644413, 2644417, 2669706, 2669709, 2669712, 2669715, 2669718, 2669721, 2679317, 2679319, 2679321, 2679323, 2679325, 2679327, 2732437, 2732440, 2732442, 2732444, 2732446, 2732448, 2732449, 2732450, 2732452, 2732454, 2732456, 2732458, 2734623, 2734626, 2734628, 2734630, 2734632, 2734634, 2734636, 2734638, 2734640, 2734642, 2734644, 2734646UNII OYN3CCI6QEUPC 0300022002045, 0300026210118, 0300021423049, 0300020152049, 0300026052114, 0300021214043, 0300026103113, 0300026612110, 0300021340049, 0300026304114, 0300026523119, 0300020243044
Pharmacologic class
GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

No drug-specific HCPCS code in Med-Code’s directory for this product.

Med-Code's directory has no drug-specific HCPCS code for Zepbound. It is usually self-administered and billed by NDC through a pharmacy benefit.

If a payer accepts an unclassified code for it in a clinical setting, that would be J3490 (Unclassified drugs), with the NDC, quantity and often the invoice. Acceptance varies by payer.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002661211 followed by a unit qualifier and the quantity

Package 00002-6612-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

ZEPBOUND ® is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 217806

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 217806
ProductStrengthForm · routeLabelerProduct NDC
ZepboundtirzepatideTirzepatide 15 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2002
ZepboundtirzepatideTirzepatide 20.8 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-6523
Zepbound KwikPentirzepatideTirzepatide 16.7 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3533
Zepbound KwikPentirzepatideTirzepatide 4.17 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3566
ZepboundtirzepatideTirzepatide 5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-0243
ZepboundtirzepatideTirzepatide 15 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2457
ZepboundtirzepatideTirzepatide 7.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2484
ZepboundtirzepatideTirzepatide 8.33 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-6103
Zepbound KwikPentirzepatideTirzepatide 25 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3511
Zepbound KwikPentirzepatideTirzepatide 12.5 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3544
ZepboundtirzepatideTirzepatide 12.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2460
ZepboundtirzepatideTirzepatide 5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2495
ZepboundtirzepatideTirzepatide 2.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-0152
ZepboundtirzepatideTirzepatide 12.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-1423
ZepboundtirzepatideTirzepatide 4.17 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-6052
ZepboundtirzepatideTirzepatide 16.7 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-6304
Zepbound KwikPentirzepatideTirzepatide 20.8 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3522
ZepboundtirzepatideTirzepatide 7.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-1214
Zepbound KwikPentirzepatideTirzepatide 8.33 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3555
ZepboundtirzepatideTirzepatide 10 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2471

Showing 20 of 23.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in